申请人:SUGEN INC
公开号:WO2005113548A1
公开(公告)日:2005-12-01
The present invention relates to thiophene heteroaryl amines and their pharmaceutically acceptable salts that modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer. Formula (I).
本发明涉及噻吩杂环芳基胺及其药用可接受盐,能调节蛋白激酶的活性,因此预计在预防和治疗蛋白激酶相关的细胞疾病,如癌症方面具有用处。化学式(I)。